Grace Therapeutics's total assets for Q1 2025 were $69.81M, a decrease of -3.04% from the previous quarter. GRCE total liabilities were $6.25M for the fiscal quarter, a 16.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.